Study of QLS-111-FDC in Open-Angle Glaucoma or Ocular Hypertension
Clinical trial NCT07354516 · COMPLETED
Trial details
- NCT number
- NCT07354516
- Sponsor
- Qlaris Bio, Inc.
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-18
- Primary completion
- 2026-07-22
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.